EGFR and non-small cell lung carcinoma: A dosage test also showed a combined THC-CBD treatment (10μM each) was the most effective at inhibiting NSCLC cell proliferation compared to separate treatments of the CBNs at 30μM each and in downregulating the gene expression of epidermal growth factor receptor (EGFR), which was not observed in the treatments with cannabinoids alone.